Retinoic acid and DFMO induce differentiation and inhibit tumor formation in neuroblastoma

2023-08-24T16:53:50-04:00April 20th, 2017|

Austin Voydanoff, Ping Zhao, Mary Durston, Giselle Saulnier Sholler. Retinoic acid and DFMO induce differentiation and inhibit tumor formation in neuroblastoma, American Association for Cancer Research (AACR) Annual Meeting, April, 2017, Washington, DC

The Signature Study: Molecular Analysis of Pediatric Tumors with Establishment of Tumor Models in a Biology Study

2023-08-24T16:54:54-04:00April 18th, 2017|

Elizabeth VanSickle, Ping Zhao, Deanna Mitchell, Jess Foley, Julie Steinbrecher, Maria Rich, Abhinav Nagulapally, Jeff Bond, Will Hendricks, Giselle Saulnier Sholler. The Signature Study: Molecular Analysis of Pediatric Tumors with Establishment of Tumor Models in a Biology Study, American Association for Cancer Research (AACR) Annual Meeting, April, 2017, Washington, DC

Cell surface vimentin is a novel marker for CTC detection in neuroblastoma

2023-08-24T16:55:39-04:00April 16th, 2017|

Izhar S. Batth, ArunSatelli, Heming Li, AbhisekMitra, HyangsoonNoh, Qing H. Meng, Saulnier Sholler G., Shulin Li. Cell surface vimentin is a novel marker for CTC detection in neuroblastoma, American Association for Cancer Research (AACR) Annual Meeting, April, 2017, Washington, DC

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

2023-08-24T16:56:24-04:00October 24th, 2016|

Giselle L. Saulnier Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, William Roberts, Randal K. Wada, Don Eslin, Javier Oesterland, Jessica Foley, Deanna Mitchell, Nehal S. Parikh, Kathleen Neville, Francis Eshun, Andre Bachmann, Debra Pankiewicz, Monique Quinn, Jacqueline M. Kraveka.  Maintenance DFMO Increases Survival in High Risk Neuroblastoma, International Society of Pediatric Oncology (SIOP), October 2016, [...]

BKM120 promotes apoptosis and suppresses tumor growth in medulloblastoma by targeting the phosphoinositide 3-kinase pathway

2023-08-28T03:09:33-04:00August 20th, 2016|

Zhao P, Hall J, Voydanoff A, Durston M, VanSickle E, Nagulapally AB, Bond J, Saulnier Sholler G, BKM120 promotes apoptosis and suppresses tumor growth in medulloblastoma by targeting the phosphoinositide 3-kinase pathway. American Association of Cancer Research (AACR) Annual Meeting, 2016.  New Orleans, LA

DFMO Maintains Remission and Increases Overall Survival in High Risk Neuroblastoma: Results of a Phase II Prevention Trial

2023-08-24T16:57:23-04:00June 24th, 2016|

Giselle L. Saulnier Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, William Roberts, Randal K. Wada, Don Eslin, Javier Oesterland, Jessica Foley, Deanna Mitchell, Nehal S. Parikh, Kathleen Neville, Francis Eshun, Andre Bachmann, Debra Pankiewicz, Monique Quinn, Jacqueline M. Kraveka. DFMO Maintains Remission and Increases Overall Survival in High Risk Neuroblastoma: Results of a Phase II [...]

A Phase II Preventative Trial of DFMO in Patients with High Risk Neuroblastoma in Remission Prevents Relapse and Increases Overall Survival

2023-08-24T16:58:03-04:00May 24th, 2016|

Giselle L. Saulnier Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, William Roberts, Randal K. Wada, Don Eslin, Javier Oesterland, Jessica Foley, Deanna Mitchell, Nehal S. Parikh, Kathleen Neville, Francis Eshun, Andre Bachmann, Debra Pankiewicz, Monique Quinn, Jacqueline M. Kraveka. A Phase II Preventative Trial of DFMO in Patients with High Risk Neuroblastoma in Remission Prevents Relapse [...]

HDAC inhibitor panobinostat as a selective agent, synergizes with chemotherapeutics in medulloblastoma and neuroblastoma

2023-08-24T16:59:04-04:00April 24th, 2016|

Witte A, Durston M, Zhao P, Nagulapally AB, Bond J, Saulnier Sholler G, HDAC inhibitor panobinostat as a selective agent, synergizes with chemotherapeutics in medulloblastoma and neuroblastoma.  American Association of Cancer Research (AACR) Annual Meeting, 2016.  New Orleans, LA

Go to Top